Hyloris Announces Approval Of Condylox First Generic

US FDA Authorizes Podofilox Product With 180-Day CGT Exclusivity

 
• By Chloe Kent
  
FDA building.
Approval marks Hyloris' second in the US this year after Maxigesic IV • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin